Abstract:After suffering pulmonary embolism (PE), doctors are confronted with various consequences of the disease, from asymptomatic residual pulmonary thrombosis to the formation of chronic thromboembolic pulmonary hypertension (CTEPH). There is also a subgroup of patients who have undergone pulmonary embolism, who experience shortness of breath during physical exertion, absent before pulmonary embolism, or shortened dyspnea preceding PE, combined with residual thrombosis of pulmonary artery (PA) and normal average pressure in PA at rest during catheterization of the right heart (CRH). This condition is defined as chronic thromboembolic pulmonary disease or post thromboembolic syndrome. Pathogenetic aspects of this condition are not fully investigated. It is important to predict the development of postembolic syndrome and to develop algorithms for the diagnosis, treatment and rehabilitation of patients with symptoms and residual pulmonary thrombosis. In case of the development of pulmonary vasculopathy in some patients who have undergone pulmonary embolism, a severe life-threatening condition forms - CTEPH, characterized by an increase in pressure in the pulmonary artery, right heart failure due to the presence of organized blood clots that have entered the pulmonary vascular bed during PE. The volume of thrombotic masses does not always correlate with clinical symptoms, which indicates the importance of microvascular remodeling. If CTEPH is suspected, a diagnostic algorithm is required, including ventilation-perfusion scintigraphy, CT angiopulmonography and catheterization of the right heart. Treating a patient with CTEPH is a difficult task fora doctor. The timely referral of the patient to the center where they are involved in treatment, including surgery and CTEPH is extremely important. Timely performed thrombendarterectomy in some cases allows to completely cure the patient. In the case of inoperable CTEPH or residual pulmonary hypertension after thrombendarterectomy, balloon angioplasty of the PA is used as well as drug treatment with specific drugs that reduce the pressure in the PA (riociguat), endothelin receptor antagonists (bosentan, macitentan), prostanoids (inhalant illoprost) phosphodiesterase-5 inhibitor and combined therapy. In this article we considered some consequences directly related to PE: asymptomatic residual pulmonary thrombosis, chronic thromboembolic pulmonary disease, chronic thromboembolic pulmonary hypertension.

Late outcomes of pulmonary embolism: The post-PE syndrome

Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism

Determinants and Management of the Post–Pulmonary Embolism Syndrome

From Post-Pulmonary Embolism Functional Impairment to Chronic Thromboembolic Disease

Post-pulmonary embolism syndrome: A reminder for clinicians

Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline

Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism

Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism

[Post-pulmonary embolism syndrome: Litterature review 2024]

Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome

Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions

Symptoms Suggestive of Postpulmonary Embolism Syndrome and Utilization of Diagnostic Testing

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study

Chronic thromboembolic pulmonary disease

Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology

The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty

Acute Pulmonary Embolism: Evidence, Innovation, and Horizons

[From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension: Pathobiology and pathophysiology]

Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies

Risk Stratification and Management of Intermediate- and High-Risk Pulmonary Embolism